Anesiva to end operations, abandon merger with Arcion

01/4/2010 | American City Business Journals

Pain-drug maker Anesiva said it will file for bankruptcy protection and "immediately cease operations" instead of merging with Arcion Therapeutics. Anesiva said it could not meet certain terms of the merger, including raising $20 million in a stock sale to pay off some debt.

View Full Article in:

American City Business Journals